Cambridge,  MA 
United States
  • Booth: 1023

Definiens is a leading Artificial Intelligence (AI) – based biomarker analysis provider for immuno-oncology therapy research and development. Our consulting services use the Tissue Phenomics® methodology, which is closely integrated with histochemistry assay development, image analysis, and bioinformatics. This novel approach reveals insights within the tissue tumor microenvironment – becoming the basis for immune profiling, biomarker discovery, and patient stratification. 

For Technical Support with this webpage, please contact support